Lantheus Holdings, Inc.
- LNTH
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Radiopharmaceuticals
- Diagnostic Imaging Agents
$99.70
Today −0.29%Quote Oct 16, 2026, 08:00 PM UTC
−1.09%over the last month
Max drawdown −1.3%From 1-month high −1.1%3 months −4.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$6.51B
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$102.65
+3.0% from here
Floor
$99.64
0.1% below price
Where the price sits
19 analysts
Analyst range, low to high
$94.00$109.00
- Price $99.70
- Resistance $100.11–$101.12
- Consensus $102.65
The price is just above its floor and right under resistance. Analysts' average target sits about 3% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about LNTHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $1.07B
- Product$376.9M35.4%
- Oncology$240.4M22.6%
- PYLARIFY$240.4M22.6%
- Cardiology$88.3M8.3%
- DEFINITY$88.3M8.3%
- Strategic Partnerships And Other$19.9M1.9%
- License and Royalty Revenues$11.2M1.1%
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,193